The biosynthesis of etamycin by Streptomyces griseoviridus was investigated with the precursors, 14C-L-leucine and 14CH3-L-methionine, during short-term incubations. Both radioisotopes are rapidly incorporated into the antibiotic without significant lag. D-Leucine, but not L-leucine, inhibits etamycin formation.
Etamycin (Fig. 1) is a peptidolactone antibiotic produced by Streptomyces griseoviridus and certain other Streptomycete species.') Radiotracer studies'-3> have demonstrated that L-amino acids are the biosynthetic precursors of the etamycin molecule; for example, L-leucine is the substrate for the synthesis of D-leucine and N-,/3-dimethyl-L-leucine moieties, and L-methionine provides the source of the methyl groups found in the sarcosine, phenylsarcosine and dimethylleucine residues. Despite this information, there has been little insight into the biochemical mechanism of synthesis of the antibiotic.
We have, therefore, initiated an investigation to examine the biogenetic origin of certain amino acid components present in the antibiotic employing short-term incubations with radiolabeled precursors. Some of these experiments are described in the present communication.
Materials and Methods
Organism and Conditions of Cultivation S. griseoviridus was kindly provided by Dr. LEO VINING, Dalhousie University, Halifax, Nova Scotia. The organism was maintained on glucose-yeast extract-malt extract agar slants.') Vegetative growth was prepared as follows: 5 ml of glucose-yeast extract-malt extract (GYM) liquid medium were added to a slant of the organism; the spores and mycelium were scraped off and the contents transferred to a 250 ml Erlenmeyer flask containing 75 ml of GYM liquid medium. Incubation was carried out for 24 hours at 28°C on a gyratory shaking incubator (Model G-25, New Brunswick Scientific Co., New Brunswick, N. J.) at 240 rpm.
For production of etamycin, 5 ml of the GYM culture were transferred to a 250 ml Erlenmeyer flask containing 75 ml of a glucose-nitrate-mineral salts medium.') Incubation for various periods of time was carried out at 28°C under the conditions described for vegetative growth of S. griseoviridus. Radiochemicals L-Leucine-U-14C (227 mCi/mMole) and L-methionine-14CH8 (57.5 mCi/mMole) were purchased Radioactivity incorporated into etamycin was determined as described by KATZ and WEIssBACH°) for actinomycin. Following incubation of S. griseoviridus with a 14C-labeled substrate on a Dubnoff metabolic shaker at 28'C, 5 ml of the culture were rapidly filtered through glass wool. Two ml of the culture filtrate plus 4 ml of benzene were transferred to a ground-glass-stoppered centrifuge tube and shaken vigorously. After centrifugation, the benzene layer plus an equal volume of water were added to a second centrifuge tube, shaken and centrifuged as before. One ml of the benzene layer was then transferred to a counting vial to which 10 ml of BRAY'S liquid scintillation fluid') were added. Data are expressed as mltmoles of 14C-labeled amino acid incorporated into etamycin per 5 ml incubation. After solubilization of protein, according to the procedure of KATZ and WEISSBACH,e) radioactivity incorporated into protein (cpm per mg) was determined in BRAY'S scintillation fluid. Radioactive samples were counted in a Mark I Nuclear Chicago refrigerated liquid scintillation spectrometer.
Autoradiography and radiostrip scanning of thin-layer and paper chromatograms revealed that 90100% of the radioactivity incorporated cochromatographed with authentic etamycin. Moreover, examination of hydrolysates demonstrated that the anticipated amino acid moieties of etamycin were specifically labeled with a 14C-precursor.
Results

Influence of D-and L-Leucine on Etamycin Biosynthesis
Although etamycin possesses a residue of D-leucine, the addition of the D-enantiomer to the culture medium markedly inhibited antibiotic formation (Fig. 2) . The extent of inhibition was dependent on the concentration of D-leucine supplied and the length of the incubation. By contrast, L-leucine, up to a level of 250 /tg per ml, did not affect etamycin biosynthesis significantly. In some experiments we did observe a 10-20% inhibition of synthesis after 1 day's incubation with the L-isomer (at 100500 ltg per ml). Subsequently, however, the rate of antibiotic synthesis was similar to that noted in control flasks and, in some cases, a slight stimulation of etamycin formation was seen following 72-hours' incubation. Inhibition of etamycin formation by D-leucine appears to be directly related to antibiotic production as no reduction in mycelium synthesized was found during the incubation. These results are quite comparable to those reported previously for actinomycin,'> polymyxin,s> penicillin" and (Table 1) . Although there are 2 `leucyl' residues for each four methyl equivalents present in the antibiotic, the 14C-radiolabel from methionine was utilized more efficiently (5-to-6-fold) than the corresponding 14C-label from L-leucine. Such differences may reflect differences in the size of the endogenous amino acid pool due to the specific requirements for protein synthesis and the catabolic activities of the organism.
Influence of D-or L-Leucine on Incorporation of 14C-Labeled Precursors into Etamycin
As demonstrated in Table 2 S. griseoviridus was cultivated in GYM medium for 24 hours and then inoculated into glucose-nitrate medium. After incubation for 12 hours, L-or Dleucine was added; after an additional period of 12 hours' cultivation, 5 ml of each culture were transferred to a 50 ml Erlenmeyer flask containing 14CH3-L-methionine (21.7 mftmoles, 1.61 x 101 cpm, 7,430 cpm/mumole).
Incubation was carried out in a DUBNOFF metabolic shaker at 28°C for 30 minutes. Radioactive assays were performed as described in Materials and Methods. and antibiotic formation. 14,15)
Initially, an experiment was carried out similar to the one described in Fig. 2 ; L-ethionine, at various concentrations, was supplied to S. griseoviridus in glucose-nitrate medium. Although etamycin production was reduced markedly as a function of ethionine concentration, cell growth was severely inhibited as well. The effect of the analogue on the incorporation of 14C-radioisotopes was next explored during short-term experiments (Table 4) . Both etamycin and protein synthesis are blocked by ethionine; indeed, incorporation of the 14C-labeled precursors into protein proved to be somewhat more sensitive to the action of the analogue.
Discussion
Etamycin is classified as a heteromeric heterodetic cyclic peptide; other members of this group include such antibiotics as pyridomycin, griselimicin, staphylomycin S, doricin and vernamycin.11) Radioisotope experiments, carried out with etamycinl-3) and pyridomycin,17 have defined the biosynthetic precursors of these two antibiotics and revealed that natural L-amino acids, employed for protein synthesis, are utilized for the biogenesis of the antibiotic peptides.
Due to certain similarities in the chemical structure of etamycin with actinomycin,18> we anticipated that the mechanism of their biogenesis would also exhibit marked parallels. Both antibiotics possess L-threonine, D-amino acid, imino acid and N-methylamino acid residues. Further, the threonine residue in both substances participates (a) in an amide linkage with a non-amino acid component, (b) in lactone formation with an N-methylamino acid residue and (c) in a peptide with a n-amino acid residue in the antibiotic molecule. The present radioisotope experiments establish that the biosynthesis of etamycin as noted with actinomycine) can be investigated during short-term experiments with labeled precursors of the antibiotic; the 14C-labeled compounds are rapidly and efficiently incorporated without any significant lag. The studies with n-and L-leucine and the kinetics of incorporation of 14C-L-leucine into etamycin suggest that the D-leucine moiety in the antibiotic probably is formed via epimerization of its L-amino acid.') Such findings have been noted previously in an investigation of D-valine synthesis during actinomycin biosynthesis.° Chloramphenicol has been shown to inhibit protein synthesis by S. griseoviridus without significant inhibition of etamycin formation. These results also compare favorably with those described pre- Table 3. viously for actinomycin4) and a number of other peptide antibiotics,") indicating that a non-ribosomal mechanism of synthesis is involved in etamycin peptide formation.
By contrast, when L-ethionine was employed as a methionine analogue, both the formation of antibiotic and protein were blocked. We suggest that the utilization of short-term experiments can provide a reliable, rapid procedure for studying antibiotic biogenesis in vivo. The classical methods'' generally employed have involved several days' incubation, large amounts of radiolabeled precursor of relatively low specific radioactivity and millimolar amounts of product for analyses.
Moreover, the analyses themselves require the expenditure of considerable time and effort, some of which can be avoided by the use of micromolar amounts of material (precursors, products) of high specific radioactivity. We would also like to point out that the synthesis of an antibiotic of high specific radioactivity obtained by the general procedures described here are useful not only for studies of precursor-product relationships, but may also be of value for pharmacologic and mechanism of action investigations.
